Article Versions Notes

Gringmuth M, Walther J, Greiser S, Toussaint M, Schwalm B, Kool M, Kortmann R-D, Glasow A, Patties I. Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. International Journal of Molecular Sciences. 2022; 23(7):3815. https://doi.org/10.3390/ijms23073815

Gringmuth, Marieke, Jenny Walther, Sebastian Greiser, Magali Toussaint, Benjamin Schwalm, Marcel Kool, Rolf-Dieter Kortmann, Annegret Glasow, and Ina Patties. 2022. "Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir" International Journal of Molecular Sciences 23, no. 7: 3815. https://doi.org/10.3390/ijms23073815

Gringmuth, M., Walther, J., Greiser, S., Toussaint, M., Schwalm, B., Kool, M., Kortmann, R.-D., Glasow, A., & Patties, I. (2022). Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. International Journal of Molecular Sciences, 23(7), 3815. https://doi.org/10.3390/ijms23073815